dc.contributor.author | Aydemir, Levent | |
dc.contributor.author | Iplik, Elif Sinem | |
dc.contributor.author | Ertugrul, Baris | |
dc.contributor.author | Kasarci, Goksu | |
dc.contributor.author | Atas, Merve Nur | |
dc.contributor.author | Ulusan, Murat | |
dc.contributor.author | Ergen, Arzu | |
dc.contributor.author | Cakmakoglu, Bedia | |
dc.date.accessioned | 2021-12-21T08:45:54Z | |
dc.date.available | 2021-12-21T08:45:54Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1357-0560 | |
dc.identifier.issn | 1559-131X | |
dc.identifier.uri | https://doi.org/10.1007/s12032-021-01538-2 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1819 | |
dc.description.abstract | Oral squamous cell carcinoma patients are exhausted against the powerful chemotherapies, radiotherapies after the surgery, and their immune system is devastated during the process and antibiotic usage become inescapable. Although prescribing an antibiotic | |
dc.description.sponsorship | Scientific Research Projects Coordination Unit of Istanbul University in Istanbul, Turkey [24114] | |
dc.language.iso | English | |
dc.publisher | Humana Press Inc | |
dc.title | Levofloxacin might be safe to use for OSCC patients | |
dc.type | Article | |
dc.relation.journal | Medıcal Oncology | |
dc.identifier.issue | 8 | |
dc.identifier.volume | 38 | |
dc.identifier.doi | 10.1007/s12032-021-01538-2 | |
dc.relation.issue | 8 | |
dc.relation.volume | 38 | |